Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D000787:Angina Pectoris / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D001549:Benzamides / Q000627:therapeutic use; D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003408:Cresols / Q000627:therapeutic use; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use; D010919:Placebos; D011412:Propanolamines / Q000627:therapeutic use*; D011859:Radiography; D014280:Triglycerides / Q000097:blood
D000319:Adrenergic beta-Antagonists; D001549:Benzamides; D003408:Cresols; D010919:Placebos; D011412:Propanolamines; D014280:Triglycerides; D002784:Cholesterol; D005996:Nitroglycerin